Anhidrosis associated with long-term use of hydroxyurea in a patient with myeloproliferative neoplasm

Ann Hematol. 2022 Jul;101(7):1595-1596. doi: 10.1007/s00277-022-04790-2. Epub 2022 Feb 12.
No abstract available

Publication types

  • Letter

MeSH terms

  • Humans
  • Hydroxyurea / adverse effects
  • Hypohidrosis*
  • Myeloproliferative Disorders* / complications
  • Myeloproliferative Disorders* / drug therapy
  • Neoplasms*

Substances

  • Hydroxyurea